Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Adenocarcinoma of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00425360
What this trial is testing

Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Royal Liverpool University Hospital 1,110
Early research (Phase 1)Ended earlyNCT02671890
What this trial is testing

Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic AdenocarcinomaRefractory Malignant Solid NeoplasmStage IV Pancreatic Cancer AJCC v8
Mayo Clinic 16
Testing effectiveness (Phase 2)WithdrawnNCT06518538
What this trial is testing

Evaluate Efficacy of Devimistat in Combination With mFFX in 2nd Line Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Stage IV
Cornerstone Pharmaceuticals
Testing effectiveness (Phase 2)Looking for participantsNCT06483555
What this trial is testing

Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel

Who this might be right for
Pancreatic AdenocarcinomaMetastatic Pancreatic CancerBasal Cell Neoplasm
UNC Lineberger Comprehensive Cancer Center 104
Early research (Phase 1)Study completedNCT01643499
What this trial is testing

Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasAdenocarcinoma of the GallbladderAdenocarcinoma of Unknown Primary+37 more
University of Chicago 79
Testing effectiveness (Phase 2)Study completedNCT05673811
What this trial is testing

Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaMetastatic
Theriva Biologics SL 112
Testing effectiveness (Phase 2)Ended earlyNCT03450018
What this trial is testing

SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
British Columbia Cancer Agency 6
Early research (Phase 1)Active Not RecruitingNCT01660971
What this trial is testing

Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Metastatic Pancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage III Pancreatic Cancer AJCC v6 and v7+1 more
National Cancer Institute (NCI) 19
Early research (Phase 1)Looking for participantsNCT06393400
What this trial is testing

CHemotherapy and Stool Transplant in PDAC (CHASe-PDAC)

Who this might be right for
Unresectable or Metastatic Advanced Pancreatic Ductal Adenocarcinoma
John Lenehan 20
Testing effectiveness (Phase 2)Study completedNCT00006467
What this trial is testing

Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
Alliance for Clinical Trials in Oncology 48
Early research (Phase 1)Active Not RecruitingNCT07021066
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors

Who this might be right for
Gastric AdenocarcinomaAdvanced Pancreatic Ductal AdenocarcinomaEsophageal Adenocarcinoma+2 more
SystImmune Inc. 160
Testing effectiveness (Phase 2)Study completedNCT02195180
What this trial is testing

Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma

Who this might be right for
Pancreatic Adenocarcinoma Metastatic
ERYtech Pharma 141
Early research (Phase 1)Looking for participantsNCT06648434
What this trial is testing

MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Ductal AdenocarcinomaPancreatic CancerCancer of the Pancreas
Washington University School of Medicine 51
Testing effectiveness (Phase 2)Looking for participantsNCT07610798
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations

Who this might be right for
Advance Solid TumorsColon and Rectal CancerNon - Small Cell Lung Cancer NSCLC+4 more
Shenzhen Ionova Life Sciences Co., Ltd. 178
Early research (Phase 1)Study completedNCT03811652
What this trial is testing

A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors

Who this might be right for
Non Small Cell Lung Cancer Squamous (NSCLC-Sq)Head and Neck Squamous Cell Carcinoma (HNSCC)Small Cell Lung Cancer (SCLC)+3 more
MedImmune LLC 8
Early research (Phase 1)Ended earlyNCT03525392
What this trial is testing

Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.

Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal CancerGastric Cancer+5 more
Ipsen 14
Testing effectiveness (Phase 2)Study completedNCT03915444
What this trial is testing

Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
HonorHealth Research Institute 42
Testing effectiveness (Phase 2)Study completedNCT00102752
What this trial is testing

Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer

Who this might be right for
NeoplasmsPancreatic Neoplasms
Threshold Pharmaceuticals 47
Testing effectiveness (Phase 2)Ended earlyNCT00326911
What this trial is testing

Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Eli Lilly and Company 61
Early research (Phase 1)Study completedNCT01537107
What this trial is testing

Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more
Mayo Clinic 31
Next Page